These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17201219)

  • 21. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Martin CL; Albers JW; Pop-Busui R;
    Diabetes Care; 2014; 37(1):31-8. PubMed ID: 24356595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of metabolic therapy in prevention and treatment of adolescents with diabetic autonomic cardiovascular neuropathy].
    Ivanov DA; Gnusaev SF; Elizarova EP; Iakovlev BN
    Kardiologiia; 2010; 50(9):47-50. PubMed ID: 21118166
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute painful neuropathic cachexia in a young type I diabetic woman. A case report.
    Weintrob N; Josefsberg Z; Galazer A; Vardi P; Karp M
    Diabetes Care; 1997 Mar; 20(3):290-1. PubMed ID: 9051374
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diabetic neuropathy].
    Balabolkin MI; Kreminskaia VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(10):57-64. PubMed ID: 11081270
    [No Abstract]   [Full Text] [Related]  

  • 25. DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history.
    Pop-Busui R; Herman WH; Feldman EL; Low PA; Martin CL; Cleary PA; Waberski BH; Lachin JM; Albers JW;
    Curr Diab Rep; 2010 Aug; 10(4):276-82. PubMed ID: 20464532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lessons for pediatricians from the diabetes control and complications trial.
    Malone JI
    Pediatr Ann; 1994 Jun; 23(6):295-9. PubMed ID: 8078706
    [No Abstract]   [Full Text] [Related]  

  • 27. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
    Tankova T; Koev D; Dakovska L
    Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignancies in patients with insulin-treated diabetes mellitus.
    Kath R; Schiel R; Müller UA; Höffken K
    J Cancer Res Clin Oncol; 2000 Jul; 126(7):412-7. PubMed ID: 10929764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomechanical characteristics of peripheral diabetic neuropathy: A systematic review and meta-analysis of findings from the gait cycle, muscle activity and dynamic barefoot plantar pressure.
    Fernando M; Crowther R; Lazzarini P; Sangla K; Cunningham M; Buttner P; Golledge J
    Clin Biomech (Bristol, Avon); 2013 Oct; 28(8):831-45. PubMed ID: 24035444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The problem of the complications of diabetes].
    Ward JD
    Journ Annu Diabetol Hotel Dieu; 1984; ():321-5. PubMed ID: 6537447
    [No Abstract]   [Full Text] [Related]  

  • 31. [Does normalization of metabolism in diabetes mellitus cause regression of the neuropathy?].
    Dieterle P
    Dtsch Med Wochenschr; 1984 Jun; 109(26):1013-4. PubMed ID: 6376044
    [No Abstract]   [Full Text] [Related]  

  • 32. Overview of diabetic neuropathy.
    Younger DS; Bronfin L
    Semin Neurol; 1996 Jun; 16(2):107-13. PubMed ID: 8987123
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide.
    Sima AA; Zhang W; Li ZG; Murakawa Y; Pierson CR
    Diabetes; 2004 Jun; 53(6):1556-63. PubMed ID: 15161761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic Microvascular Complications Among Children and Adolescents in Northwestern Tanzania: A Cross-Sectional Study.
    Msanga D; Reis K; Kayange N; Bakalemwa R; Kidenya B; Hau D; Mwanansao C; Mahamba D; Ottaru S; Kwiyolecha E; Peck R
    Ann Glob Health; 2020 Apr; 86(1):43. PubMed ID: 32346524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Childhood diabetic neuropathy: functional impairment and non-invasive screening assessment.
    Blankenburg M; Kraemer N; Hirschfeld G; Krumova EK; Maier C; Hechler T; Aksu F; Magerl W; Reinehr T; Wiesel T; Zernikow B
    Diabet Med; 2012 Nov; 29(11):1425-32. PubMed ID: 22507184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of pulsed electromagnetic fields with complex modulation in the treatment of patients with diabetic polyneuropathy.
    Musaev AV; Guseinova SG; Imamverdieva SS
    Neurosci Behav Physiol; 2003 Oct; 33(8):745-52. PubMed ID: 14635988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Near-normoglycaemia and development of neuropathy: a 24-year prospective study from diagnosis of type 1 diabetes.
    Ziegler D; Behler M; Schroers-Teuber M; Roden M
    BMJ Open; 2015 Jun; 5(6):e006559. PubMed ID: 26109108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Alpha-lipoic acid in diabetic neuropathy. Action mechanism and therapy. Clinical picture and pathogenesis of diabetic neuropathy].
    Internist (Berl); 1994 Jun; 35(6 Alpha-liponsa):1-4. PubMed ID: 9532228
    [No Abstract]   [Full Text] [Related]  

  • 39. [Not Available].
    Keller U
    Ther Umsch; 2017; 74(8):454-461. PubMed ID: 29461146
    [No Abstract]   [Full Text] [Related]  

  • 40. Higher risk of microvascular complications in smokers with type 1 diabetes despite intensive insulin therapy.
    Uruska A; Araszkiewicz A; Uruski P; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2014 Mar; 92():79-84. PubMed ID: 24423616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.